1000 Participants Needed

Social Determinants for Liver and Bile Duct Cancer

CT
Overseen ByClinical Trials Referral Office
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on understanding the challenges faced by people with hepatobiliary cancer in accessing care and identifying factors that might increase their risk of developing this type of cancer. Participants will complete a questionnaire and provide samples such as blood, urine, and tissue, along with their medical records. This information will help researchers identify social factors that impact patient health and treatment. Individuals diagnosed with hepatobiliary cancer might be a good fit for this study. As an unphased study, this trial offers a unique opportunity to contribute to research that could improve care access and outcomes for future patients.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to uncover how social factors like lifestyle, environment, and socioeconomic status impact hepatobiliary cancer patients. Unlike traditional studies focusing solely on the biological aspects of cancer, this trial collects comprehensive data through questionnaires and various biological samples, including blood, urine, and tissue samples. By examining these social determinants of health, researchers hope to identify new ways to improve patient outcomes and tailor treatments more effectively. This could lead to more personalized healthcare strategies that account for a patient's unique social and environmental context.

Who Is on the Research Team?

NH

Nguyen H. Tran, M.D.

Principal Investigator

Mayo Clinic in Rochester

Are You a Good Fit for This Trial?

Inclusion Criteria

You are an adult of 18 years or older with a diagnosis of hepatobiliary cancer.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational Study

Participants complete a questionnaire, undergo blood, urine, and buccal swab sample collection, and have their medical records reviewed. Clinically archived tissue samples are also collected.

Baseline; up to 2 years

Follow-up

Participants are monitored for safety and effectiveness after the observational study activities

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Interventional Study

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+